Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular Carcinoma

NCT00667628 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to safety concerns.

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: TAC-101
DRUG: Placebo

Sponsor

Taiho Oncology, Inc.

Collaborators

[object Object]